<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03740000_2</Organism_ID>
  <Organism>HCV NS3 protein</Organism>
  <Organism_Latin>Hepatitis C virus</Organism_Latin>
  <UniProt_ID>P06935</UniProt_ID>
  <Seq_Length>3430</Seq_Length>
  <Molecule_Weight>380110</Molecule_Weight>
  <EBI_ID>EBI-981051</EBI_ID>
  <Function_Summary>Capsid protein C self-assembles to form an icosahedral capsid about 30 nm in diameter. The capsid encapsulates the genomic RNA (By similarity).prM acts as a chaperone for envelope protein E during intracellular virion assembly by masking and inactivating envelope protein E fusion peptide. prM is matured in the last step of virion assembly, presumably to avoid catastrophic activation of the viral fusion peptide induced by the acidic pH of the trans-Golgi network. After cleavage by host furin, the pr peptide is released in the extracellular medium and small envelope protein M and envelope protein E homodimers are dissociated (By similarity).Envelope protein E binding to host cell surface receptor is followed by virus internalization through clathrin-mediated endocytosis. Envelope protein E is subsequently involved in membrane fusion between virion and host late endosomes. Synthesized as a homodimer with prM which acts as a chaperone for envelope protein E. After cleavage of prM, envelope protein E dissociate from small envelope protein M and homodimerizes (By similarity).Non-structural protein 1 is involved in virus replication and regulation of the innate immune response (By similarity).Non-structural protein 2A may be involved viral RNA replication and capsid assembly (Potential).Non-structural protein 2B is a required cofactor for the serine protease function of NS3 (By similarity).Serine protease NS3 displays three enzymatic activities: serine protease, NTPase and RNA helicase. NS3 serine protease, in association with NS2B, performs its autocleavage and cleaves the polyprotein at dibasic sites in the cytoplasm: C-prM, NS2A-NS2B, NS2B-NS3, NS3-NS4A, NS4A-2K and NS4B-NS5. NS3 RNA helicase binds RNA and unwinds dsRNA in the 3' to 5' direction (By similarity).Non-structural protein 4A induces host endoplasmic reticulum membrane rearrangements leading to the formation of virus-induced membranous vesicles hosting the dsRNA and polymerase, functioning as a replication complex. NS4A might also regulate the ATPase activity of the NS3 helicase (By similarity).Peptide 2k functions as a signal peptide for NS4B and is required for the interferon antagonism activity of the latter (By similarity).Non-structural protein 4B inhibits interferon (IFN)-induced host STAT1 phosphorylation and nuclear translocation, thereby preventing the establishment of cellular antiviral state by blocking the IFN-alpha/beta pathway (By similarity).RNA-directed RNA polymerase NS5 replicates the viral (+) and (-) genome, and performs the capping of genomes in the cytoplasm. NS5 methylates viral RNA cap at guanine N-7 and ribose 2'-O positions. Besides its role in genome replication, also prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta (IFN-alpha/beta) signaling pathway. Inhibits host JAK1 and TYK2 phosphorylation, thereby preventing activation of JAK-STAT signaling pathway (By similarity).</Function_Summary>
  <Catalytic_Mechanism>Selective hydrolysis of -Xaa-Xaa-|-Yaa- bonds in which each of the Xaa can be either Arg or Lys and Yaa can be either Ser or Ala.@@Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).@@NTP + H(2)O = NDP + phosphate.@@ATP + H(2)O = ADP + phosphate.@@S-adenosyl-L-methionine + G(5')pppR-RNA = S-adenosyl-L-homocysteine + m(7)G(5')pppR-RNA.@@S-adenosyl-L-methionine + m(7)G(5')pppR-RNA = S-adenosyl-L-homocysteine + m(7)G(5')pppRm-RNA.</Catalytic_Mechanism>
  <Pfam_ID>PF01003:Flavi_capsid@@PF07652:Flavi_DEAD@@PF02832:Flavi_glycop_C@@PF00869:Flavi_glycoprot@@PF01004:Flavi_M@@PF00948:Flavi_NS1@@PF01005:Flavi_NS2A@@PF01002:Flavi_NS2B@@PF01350:Flavi_NS4A@@PF01349:Flavi_NS4B@@PF00972:Flavi_NS5@@PF01570:Flavi_propep@@PF01728:FtsJ@@PF00271:Helicase_C@@PF00949:Peptidase_S7</Pfam_ID>
  <Allosteric_Activator_Count>7</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>268</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Flavivirin protease NS2B regulatory subunit</Alias>
      <Alias>Peptide 2k</Alias>
      <Alias>RNA-directed RNA polymerase NS5</Alias>
      <Alias>Core protein</Alias>
      <Alias>Small envelope protein M</Alias>
      <Alias>Non-structural protein 4A</Alias>
      <Alias>Peptide pr</Alias>
      <Alias>NS1</Alias>
      <Alias>NS5</Alias>
      <Alias>Non-structural protein 3</Alias>
      <Alias>Non-structural protein 1</Alias>
      <Alias>prM</Alias>
      <Alias>NS4B</Alias>
      <Alias>Flavivirin protease NS3 catalytic subunit</Alias>
      <Alias>Capsid protein C</Alias>
      <Alias>Envelope protein E</Alias>
      <Alias>NS4A</Alias>
      <Alias>Serine protease subunit NS2B</Alias>
      <Alias>Non-structural protein 2B</Alias>
      <Alias>Non-structural protein 4B</Alias>
      <Alias>Matrix protein</Alias>
      <Alias>Serine protease NS3</Alias>
      <Alias>Non-structural protein 2A</Alias>
      <Alias>NS2A</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the transfer of a nucleotidyl group to a reactant.</Detail>
      <Keyword>Nucleotidyltransferase activity</Keyword>
      <Ontology_ID>GO:0016779</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a methyl group to an acceptor molecule.</Detail>
      <Keyword>Methyltransferase activity</Keyword>
      <Ontology_ID>GO:0008168</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>The action of a molecule that contributes to the structural integrity of a complex or assembly within or outside a cell.</Detail>
      <Keyword>Structural molecule activity</Keyword>
      <Ontology_ID>GO:0005198</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with double-stranded RNA.</Detail>
      <Keyword>Double-stranded RNA binding</Keyword>
      <Ontology_ID>GO:0003725</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008236</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + H2O = ADP + phosphate, to drive the unwinding of a DNA or RNA helix.</Detail>
      <Keyword>ATP-dependent helicase activity</Keyword>
      <Ontology_ID>GO:0008026</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); uses an RNA template.</Detail>
      <Keyword>RNA-directed RNA polymerase activity</Keyword>
      <Ontology_ID>GO:0003968</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004252</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: NTP + H2O = NDP + phosphate, to drive the unwinding of a RNA helix.</Detail>
      <Keyword>RNA helicase activity</Keyword>
      <Ontology_ID>GO:0003724</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an RNA molecule or a portion thereof.</Detail>
      <Keyword>RNA binding</Keyword>
      <Ontology_ID>GO:0003723</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: NTP + H2O = NDP + phosphate, to drive the unwinding of a DNA or RNA helix.</Detail>
      <Keyword>Helicase activity</Keyword>
      <Ontology_ID>GO:0004386</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond not more than three residues from the N- or C-terminus of a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type exopeptidase activity</Keyword>
      <Ontology_ID>GO:0070008</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: S-adenosyl-L-methionine + m7G(5')pppR-RNA = S-adenosyl-L-homocysteine + m7G(5')pppRm-RNA. R may be guanosine or adenosine.</Detail>
      <Keyword>MRNA (nucleoside-2'-O-)-methyltransferase activity</Keyword>
      <Ontology_ID>GO:0004483</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: S-adenosyl-L-methionine + G(5')pppR-RNA = S-adenosyl-L-homocysteine + m7G(5')pppR-RNA. m7G(5')pppR-RNA is mRNA containing an N7-methylguanine cap; R may be guanosine or adenosine.</Detail>
      <Keyword>MRNA (guanine-N7-)-methyltransferase activity</Keyword>
      <Ontology_ID>GO:0004482</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.</Detail>
      <Keyword>MRNA processing</Keyword>
      <Ontology_ID>GO:0006397</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of DNA on a template of RNA.</Detail>
      <Keyword>Transcription, RNA-dependent</Keyword>
      <Ontology_ID>GO:0006410</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the merging of the virion membrane with the host membrane during viral penetration or egress in host cell. Viral fusion proteins drive this fusion reaction by undergoing a major conformational change that is triggered by interactions with the target cell. The specific trigger depends on the virus and can be exposure to low pH in the endocytic pathway or interaction of the virion with the host receptor(s).</Detail>
      <Keyword>Fusion of virus membrane with host membrane</Keyword>
      <Ontology_ID>KW-1168</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in virus internalization by the host cell via clathrin-mediated endocytosis. In response to an internalization signal, clathrin is assembled on the inside face of the cell membrane to form characteristic invaginations or clathrin coated pits that pinch off through the action of DNM1/Dynamin-1 or DNM2/Dynamin-2. The virus bound to its host cell receptor is internalized into clathrin-coated vesicles (CCV). Endocytic CCV deliver their viral content to early endosomes. The endosomal acidic pH and/or receptor binding usually induces structural modifications of the virus surface proteins that lead to penetration of the endosomal membrane via fusion or permeabilization mechanisms.</Detail>
      <Keyword>Clathrin-mediated endocytosis of virus by host</Keyword>
      <Ontology_ID>KW-1165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the evasion of host innate immune response. Upon viral infection, the innate immune system initially defends the host in a non-specific manner. Many viral proteins interact with and inhibit components the host innate system to replicate more efficiently.</Detail>
      <Keyword>Inhibition of host innate immune response by virus</Keyword>
      <Ontology_ID>KW-1090</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the evasion of the type I, II and III interferon pathways by inhibiting the JAK1 protein. Upon viral infection, JAK1 is activated by the interferon-alpha/beta, -gamma, and -lambda signal transduction pathways. Several viral proteins can directly interact with JAK1 to prevent its ability to phosphorylate the downstream partners STAT1 or STAT2.</Detail>
      <Keyword>Inhibition of host JAK1 by virus</Keyword>
      <Ontology_ID>KW-1096</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the virion's initiation of infection into a host cell, including internalization and penetration into the host cell cytoplasm, intracellular transport of viral components and genome release to the replication site of the virus.</Detail>
      <Keyword>Initiation of viral infection</Keyword>
      <Ontology_ID>KW-1160</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the activation of host autophagy. Autophagy is a major intracellular pathway in the delivery of cytoplasmic material to lysosomes for degradation. It is also essential for the removal of pathogenic protein aggregates from the cell during infection. Although autophagy is clearly important for antiviral immune response, it can also be activated by viruses and serves as platform for viral replication. Some viruses such as poliovirus, use the autophagic pathway as a nonlytic mechanism for viral release.</Detail>
      <Keyword>Activation of host autophagy by virus</Keyword>
      <Ontology_ID>KW-1072</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the entry of the entire virion or its genetic material into the host cell cytoplasm. Entry is achieved through pore formation, membrane fusion and/or endocytosis mechanisms. Penetration reactions occur mainly in five locations: the cell membrane, early and late endosomes, caveosomes, and the ER.</Detail>
      <Keyword>Viral penetration into host cytoplasm</Keyword>
      <Ontology_ID>KW-1162</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of cellular DNA-dependent transcription.</Detail>
      <Keyword>Regulation of transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006355</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of RNA on a template of DNA.</Detail>
      <Keyword>Transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006351</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process, either active or passive, by which a virus avoids the effects of the host organism's immune response. The host is defined as the larger of the organisms involved in a symbiotic interaction.</Detail>
      <Keyword>Evasion by virus of host immune response</Keyword>
      <Ontology_ID>GO:0030683</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Transcription</Keyword>
      <Ontology_ID>GO:0006350</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved directly in viral genome replication, including viral nucleotide metabolism.</Detail>
      <Keyword>Viral genome replication</Keyword>
      <Ontology_ID>GO:0019079</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the evasion of the type I and III interferon pathways by inhibiting the host TYK2 protein. Upon viral infection, the TYK2 protein is activated by IFNalpha/beta or IFN-lambda stimulation leading to a series of phosphorylation events that induce transcription of several hundred IFN-responsive genes. Several viruses have evolved mechanisms to inhibit TYK2 activity thereby preventing the subsequent activation of downstream partners STAT1 and STAT2.</Detail>
      <Keyword>Inhibition of host TYK2 by virus</Keyword>
      <Ontology_ID>KW-1112</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the merging of the virus envelope with host endosomal membrane during viral penetration into host cell. Viral fusion proteins drive this fusion reaction by undergoing a major conformational change that is triggered by interactions with the target cell. The specific trigger is mainly endosome acidification which induce activation of the fusion protein by conformational change. This pathway is used by enveloped viruses which are endocytosed and whose fusion protein is usually pH-dependent like influenza A virus, rhabdoviruses, bornaviruses, filoviruses, asfarviridae, flaviviridae, alphaviruses, HIV-1, avian leukosis virus, SARS, 229E, and MHV-2 coronaviruses.</Detail>
      <Keyword>Fusion of virus membrane with host endosomal membrane</Keyword>
      <Ontology_ID>KW-1170</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Regulation of transcription</Keyword>
      <Ontology_ID>GO:0045449</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the specific binding of a viral antireceptor to a cell surface receptor.</Detail>
      <Keyword>Virion attachment to host cell surface receptor</Keyword>
      <Ontology_ID>GO:0019062</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in the evasion of host innate defense by inhibiting the interferon signaling pathway leading to the production of interferon-induced genes. Interferons bind to the IFN receptors (IFNAR) on the cell surface and activate Jak/Tyk kinases. These kinases phosphorylate STAT1 and STAT2 that translocate to the nucleus and induce the expression of interferon stimulated genes (ISGs). Many viruses interact with components of this pathway to prevent expression of ISGs and inhibit the host immune response.</Detail>
      <Keyword>Inhibition of host interferon signaling pathway by virus</Keyword>
      <Ontology_ID>KW-1114</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral surface protein implicated in the binding to specific host surface molecule(s). This binding can lead to virion entry into the host cell, it can trigger signaling pathways, or it can allow the virion to be carried by the host cell to a specific organ.</Detail>
      <Keyword>Viral attachment to host cell</Keyword>
      <Ontology_ID>KW-1161</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Viral protein involved in virus internalization by the host cell via receptor-mediated endocytosis. Receptor mediated endocytosis can occur via: clathrin-mediated endocytosis, caveolin-mediated endocytosis or clathrin- and caveolae-independent endocytosis.</Detail>
      <Keyword>Receptor mediated endocytosis of virus by host</Keyword>
      <Ontology_ID>KW-1164</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Addition of the 7-methylguanosine cap to the 5' end of a nascent messenger RNA transcript.</Detail>
      <Keyword>MRNA capping</Keyword>
      <Ontology_ID>GO:0006370</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MSKKPGGPGKNRAVNMLKRGMPRGLSLIGLKRAMLSLIDGKGPIRFVLALLAFFRFTAIAPTRAVLDRWRGVNKQTAMKHLLSFKKELGTLTSAINRRSTKQKKRGGTAGFTILLGLIACAGAVTLSNFQGKVMMTVNATDVTDVITIPTAAGKNLCIVRAMDVGYLCEDTITYECPVLAAGNDPEDIDCWCTKSSVYVRYGRCTKTRHSRRSRRSLTVQTHGESTLANKKGAWLDSTKATRYLVKTESWILRNPGYALVAAVIGWMLGSNTMQRVVFAILLLLVAPAYSFNCLGMSNRDFLEGVSGATWVDLVLEGDSCVTIMSKDKPTIDVKMMNMEAANLADVRSYCYLASVSDLSTRAACPTMGEAHNEKRADPAFVCKQGVVDRGWGNGCGLFGKGSIDTCAKFACTTKATGWIIQKENIKYEVAIFVHGPTTVESHGKIGATQAGRFSITPSAPSYTLKLGEYGEVTVDCEPRSGIDTSAYYVMSVGEKSFLVHREWFMDLNLPWSSAGSTTWRNRETLMEFEEPHATKQSVVALGSQEGALHQALAGAIPVEFSSNTVKLTSGHLKCRVKMEKLQLKGTTYGVCSKAFKFARTPADTGHGTVVLELQYTGTDGPCKVPISSVASLNDLTPVGRLVTVNPFVSVATANSKVLIELEPPFGDSYIVVGRGEQQINHHWHKSGSSIGKAFTTTLRGAQRLAALGDTAWDFGSVGGVFTSVGKAIHQVFGGAFRSLFGGMSWITQGLLGALLLWMGINARDRSIAMTFLAVGGVLLFLSVNVHADTGCAIDIGRQELRCGSGVFIHNDVEAWMDRYKFYPETPQGLAKIIQKAHAEGVCGLRSVSRLEHQMWEAIKDELNTLLKENGVDLSVVVEKQNGMYKAAPKRLAATTEKLEMGWKAWGKSIIFAPELANNTFVIDGPETEECPTANRAWNSMEVEDFGFGLTSTRMFLRIRETNTTECDSKIIGTAVKNNMAVHSDLSYWIESGLNDTWKLERAVLGEVKSCTWPETHTLWGDGVLESDLIIPITLAGPRSNHNRRPGYKTQNQGPWDEGRVEIDFDYCPGTTVTISDSCEHRGPAARTTTESGKLITDWCCRSCTLPPLRFQTENGCWYGMEIRPTRHDEKTLVQSRVNAYNADMIDPFQLGLMVVFLATQEVLRKRWTAKISIPAIMLALLVLVFGGITYTDVLRYVILVGAAFAEANSGGDVVHLALMATFKIQPVFLVASFLKARWTNQESILLMLAAAFFQMAYYDAKNVLSWEVPDVLNSLSVAWMILRAISFTNTSNVVVPLLALLTPGLKCLNLDVYRILLLMVGVGSLIKEKRSSAAKKKGACLICLALASTGVFNPMILAAGLMACDPNRKRGWPATEVMTAVGLMFAIVGGLAELDIDSMAIPMTIAGLMFAAFVISGKSTDMWIERTADITWESDAEITGSSERVDVRLDDDGNFQLMNDPGAPWKIWMLRMACLAISAYTPWAILPSVIGFWITLQYTKRGGVLWDTPSPKEYKKGDTTTGVYRIMTRGLLGSYQAGAGVMVEGVFHTLWHTTKGAALMSGEGRLDPYWGSVKEDRLCYGGPWKLQHKWNGHDEVQMIVVEPGKNVKNVQTKPGVFKTPEGEIGAVTLDYPTGTSGSPIVDKNGDVIGLYGNGVIMPNGSYISAIVQGERMEEPAPAGFEPEMLRKKQITVLDLHPGAGKTRKILPQIIKEAINKRLRTAVLAPTRVVAAEMSEALRGLPIRYQTSAVHREHSGNEIVDVMCHATLTHRLMSPHRVPNYNLFIMDEAHFTDPASIAARGYIATKVELGEAAAIFMTATPPGTSDPFPESNAPISDMQTEIPDRAWNTGYEWITEYVGKTVWFVPSVKMGNEIALCLQRAGKKVIQLNRKSYETEYPKCKNDDWDFVITTDISEMGANFKASRVIDSRKSVKPTIIEEGDGRVILGEPSAITAASAAQRRGRIGRNPSQVGDEYCYGGHTNEDDSNFAHWTEARIMLDNINMPNGLVAQLYQPEREKVYTMDGEYRLRGEERKNFLEFLRTADLPVWLAYKVAAAGISYHDRKWCFDGPRTNTILEDNNEVEVITKLGERKILRPRWADARVYSDHQALKSFKDFASGKRSQIGLVEVLGRMPEHFMVKTWEALDTMYVVATAEKGGRAHRMALEELPDALQTIVLIALLSVMSLGVFFLLMQRKGIGKIGLGGVILGAATFFCWMAEVPGTKIAGMLLLSLLLMIVLIPEPEKQRSQTDNQLAVFLICVLTLVGAVAANEMGWLDKTKNDIGSLLGHRPEARETTLGVESFLLDLRPATAWSLYAVTTAVLTPLLKHLITSDYINTSLTSINVQASALFTLARGFPFVDVGVSALLLAVGCWGQVTLTVTVTAAALLFCHYAYMVPGWQAEAMRSAQRRTAAGIMKNVVVDGIVATDVPELERTTPVMQKKVGQIILILVSMAAVVVNPSVRTVREAGILTTAAAVTLWENGASSVWNATTAIGLCHIMRGGWLSCLSIMWTLIKNMEKPGLKRGGAKGRTLGEVWKERLNHMTKEEFTRYRKEAITEVDRSAAKHARREGNITGGHPVSRGTAKLRWLVERRFLEPVGKVVDLGCGRGGWCYYMATQKRVQEVKGYTKGGPGHEEPQLVQSYGWNIVTMKSGVDVFYRPSEASDTLLCDIGESSSSAEVEEHRTVRVLEMVEDWLHRGPKEFCIKVLCPYMPKVIEKMETLQRRYGGGLIRNPLSRNSTHEMYWVSHASGNIVHSVNMTSQVLLGRMEKKTWKGPQFEEDVNLGSGTRAVGKPLLNSDTSKIKNRIERLKKEYSSTWHQDANHPYRTWNYHGSYEVKPTGSASSLVNGVVRLLSKPWDTITNVTTMAMTDTTPFGQQRVFKEKVDTKAPEPPEGVKYVLNETTNWLWAFLARDKKPRMCSREEFIGKVNSNAALGAMFEEQNQWKNAREAVEDPKFWEMVDEEREAHLRGECNTCIYNMMGKREKKPGEFGKAKGSRAIWFMWLGARFLEFEALGFLNEDHWLGRKNSGGGVEGLGLQKLGYILKEVGTKPGGKVYADDTAGWDTRITKADLENEAKVLELLDGEHRRLARSIIELTYRHKVVKVMRPAADGKTVMDVISREDQRGSGQVVTYALNTFTNLAVQLVRMMEGEGVIGPDDVEKLGKGKGPKVRTWLFENGEERLSRMAVSGDDCVVKPLDDRFATSLHFLNAMSKVRKDIQEWKPSTGWYDWQQVPFCSNHFTELIMKDGRTLVVPCRGQDELIGRARISPGAGWNVRDTACLAKSYAQMWLLLYFHRRDLRLMANAICSAVPANWVPTGRTTWSIHAKGEWMTTEDMLAVWNRVWIEENEWMEDKTPVERWSDVPYSGKREDIWCGSLIGTRTRATWAENIHVAINQVRSVIGEEKYVDYMSSLRRYEDTIVVEDTVL</Protein_Seq>
    <DNA_Seq>AGTAGTTCGCCTGTGTGAGCTGACAAACTTAGTAGTGTTTGTGAGGATTAACAACAATTAACACAGTGCGAGCTGTTTCTTGGCACGAAGATCTCGATGTCTAAGAAACCAGGAGGGCCCGGTAAAAACCGGGCTGTCAATATGCTAAAACGCGGTATGCCCCGCGGATTGTCCTTGATAGGACTAAAGAGGGCTATGCTGAGTCTGATTGACGGGAAGGGCCCAATACGTTTCGTGTTGGCTCTTTTGGCGTTTTTCAGATTCACTGCAATCGCTCCGACTCGTGCGGTGCTGGACAGATGGAGAGGCGTCAACAAACAAACAGCAATGAAGCATCTCTTGAGTTTCAAGAAAGAACTAGGAACTCTGACCAGTGCCATCAACCGCCGGAGCACAAAACAAAAGAAAAGAGGAGGCACAGCGGGCTTTACTATCTTGCTTGGGCTGATCGCCTGTGCTGGAGCTGTGACCCTCTCGAACTTCCAGGGCAAAGTGATGATGACAGTCAATGCAACCGATGTCACTGACGTGATTACCATTCCAACAGCTGCTGGGAAAAACCTGTGCATCGTAAGGGCTATGGACGTAGGATACCTTTGTGAGGATACTATCACTTATGAATGTCCGGTCCTAGCTGCTGGAAATGACCCTGAAGACATTGACTGCTGGTGCACGAAATCATCTGTTTACGTGCGCTATGGAAGATGCACAAAAACTCGGCATTCCCGTCGAAGCAGAAGGTCTCTGACAGTCCAGACACATGGAGAAAGTACACTGGCCAACAAGAAAGGAGCTTGGTTGGACAGCACAAAAGCCACGAGATATCTGGTGAAGACAGAATCATGGATACTGAGAAACCCGGGCTACGCCCTCGTTGCAGCTGTCATTGGATGGATGCTAGGAAGCAACACAATGCAACGCGTCGTGTTTGCCATTCTATTGCTCCTGGTGGCACCAGCATACAGCTTCAACTGTTTAGGAATGAGTAACAGAGACTTCCTGGAGGGAGTGTCTGGAGCTACATGGGTTGATCTGGTACTGGAAGGCGATAGTTGTGTGACCATAATGTCAAAAGACAAGCCAACCATTGATGTCAAAATGATGAACATGGAAGCAGCCAACCTCGCAGATGTGCGCAGTTACTGTTACCTAGCTTCGGTCAGTGACTTGTCAACAAGAGCTGCGTGTCCAACCATGGGTGAAGCCCACAACGAGAAAAGAGCTGACCCCGCCTTCGTTTGCAAGCAAGGCGTTGTGGACAGAGGATGGGGAAATGGCTGCGGACTGTTTGGAAAGGGGAGCATTGACACATGTGCGAAGTTTGCCTGTACAACCAAAGCAACTGGATGGATCATCCAGAAGGAAAACATCAAGTATGAGGTTGCCATATTTGTGCATGGCCCGACGACCGTTGAATCTCATGGCAAGATAGGGGCCACCCAGGCTGGAAGATTCAGTATAACTCCATCGGCGCCATCTTACACGCTAAAGTTGGGTGAGTATGGTGAGGTTACGGTTGATTGTGAGCCACGGTCAGGAATAGACACCAGCGCCTATTACGTTATGTCAGTTGGTGAGAAGTCCTTCCTGGTTCACCGAGAATGGTTTATGGATCTGAACCTGCCATGGAGCAGTGCTGGAAGCACCACGTGGAGGAACCGGGAAACACTGATGGAGTTTGAAGAACCTCATGCCACCAAACAATCTGTTGTGGCTCTAGGGTCGCAGGAAGGTGCGTTGCACCAAGCTCTGGCCGGAGCGATTCCTGTTGAGTTCTCAAGCAACACTGTGAAGTTGACATCAGGACATCTGAAGTGTCGGGTGAAGATGGAGAAGTTGCAGCTGAAGGGAACAACATATGGAGTATGTTCAAAAGCGTTCAAATTCGCTAGGACTCCCGCTGACACTGGCCACGGAACGGTGGTGTTGGAACTGCAATATACCGGAACAGACGGTCCCTGCAAAGTGCCCATTTCTTCCGTAGCTTCCCTGAATGACCTCACACCTGTTGGAAGACTGGTGACCGTGAATCCATTTGTGTCTGTGGCCACAGCCAACTCGAAGGTTTTGATTGAACTCGAACCCCCGTTTGGTGACTCTTACATCGTGGTGGGAAGAGGAGAACAGCAGATAAACCATCACTGGCACAAATCTGGGAGCAGCATTGGAAAGGCCTTTACCACCACACTCAGAGGAGCTCAACGACTCGCAGCTCTTGGAGATACTGCTTGGGATTTTGGATCAGTTGGAGGGGTTTTCACCTCAGTGGGGAAAGCCATACACCAAGTCTTTGGAGGAGCTTTTAGATCACTCTTTGGAGGGATGTCCTGGATCACACAGGGACTTCTGGGAGCTCTTCTGTTGTGGATGGGAATCAATGCCCGTGACAGGTCAATTGCTATGACGTTTCTTGCGGTTGGAGGAGTTTTGCTCTTCCTTTCGGTCAACGTCCATGCTGACACAGGCTGTGCCATTGATATTGGCAGGCAAGAGCTCCGGTGCGGAAGTGGAGTGTTTATCCACAACGATGTGGAAGCCTGGATGGATCGTTACAAGTTCTACCCGGAGACGCCACAGGGCCTAGCAAAAATTATCCAGAAAGCACATGCAGAAGGAGTCTGCGGCTTGCGTTCCGTTTCCAGACTCGAGCACCAAATGTGGGAAGCCATTAAGGATGAGCTGAACACCCTGTTGAAAGAGAATGGAGTCGACTTGAGTGTCGTGGTGGAAAAACAGAATGGGATGTACAAAGCAGCACCAAAACGTTTGGCTGCCACCACCGAAAAACTGGAGATGGGTTGGAAGGCTTGGGGCAAGAGTATCATCTTTGCGCCAGAACTAGCTAACAACACCTTTGTCATCGACGGTCCTGAGACTGAGGAATGCCCAACGGCCAACCGAGCATGGAACAGTATGGAGGTAGAGGACTTTGGATTTGGACTGACAAGCACTCGCATGTTCCTGAGGATTCGGGAAACGAACACAACGGAATGCGACTCGAAGATCATAGGAACCGCCGTCAAGAACAACATGGCTGTGCATAGTGATCTATCATACTGGATAGAGAGCGGACTCAACGACACCTGGAAGCTTGAGAGGGCGGTTCTAGGAGAAGTCAAATCATGCACCTGGCCAGAAACCCACACTCTGTGGGGTGATGGAGTTCTGGAAAGTGATCTCATCATACCCATCACCTTGGCAGGACCCAGAAGCAACCACAACAGGAGACCAGGGTACAAAACTCAGAACCAAGGCCCATGGGATGAGGGGCGCGTCGAGATTGACTTTGACTATTGCCCAGGAACAACAGTAACTATAAGTGACAGTTGCGAACACCGTGGACCTGCGGCACGCACAACCACTGAGAGTGGGAAGCTCATCACAGACTGGTGCTGCAGAAGTTGCACCCTCCCTCCACTGCGCTTCCAGACTGAGAATGGCTGTTGGTATGGAATGGAAATTCGACCTACGCGGCACGACGAAAAGACCCTCGTGCAATCGAGAGTGAATGCATACAACGCCGACATGATTGATCCTTTTCAGTTGGGCCTTATGGTCGTGTTCTTGGCCACCCAGGAGGTCCTTCGCAAGAGGTGGACGGCCAAGATCAGCATTCCAGCTATCATGCTTGCACTCCTAGTCCTAGTGTTTGGGGGTATTACGTACACTGATGTCCTGCGATATGTCATTCTCGTCGGCGCCGCGTTTGCTGAAGCAAACTCAGGAGGAGACGTCGTGCACTTGGCACTTATGGCTACATTCAAGATTCAACCAGTCTTTCTGGTGGCTTCCTTTTTGAAGGCAAGGTGGACCAACCAAGAGAGTATTTTGCTCATGCTTGCAGCTGCTTTCTTCCAAATGGCTTACTATGACGCCAAGAATGTTCTGTCATGGGAAGTGCCTGACGTTTTGAACTCTCTCTCCGTTGCGTGGATGATTCTCAGAGCTATAAGCTTCACCAACACTTCAAATGTGGTGGTGCCGCTGCTGGCCCTTTTGACACCTGGATTGAAATGCTTAAACCTTGATGTGTACAGAATTTTGCTACTCATGGTTGGAGTTGGAAGCCTCATCAAAGAAAAAAGGAGCTCTGCAGCAAAAAAGAAAGGAGCTTGCCTCATCTGCCTAGCGCTGGCGTCTACAGGAGTGTTCAATCCAATGATACTTGCAGCTGGGCTAATGGCTTGCGACCCCAACCGCAAGCGGGGCTGGCCTGCTACAGAAGTGATGACTGCAGTTGGACTCATGTTTGCCATCGTTGGGGGTCTGGCAGAACTTGACATAGATTCTATGGCTATCCCCATGACCATCGCCGGACTTATGTTCGCGGCATTTGTCATCTCTGGAAAGTCAACAGACATGTGGATTGAGAGGACGGCTGACATTACTTGGGAGAGTGATGCTGAAATCACAGGCTCTAGCGAAAGAGTAGATGTGAGGCTGGATGATGATGGAAATTTTCAACTGATGAATGACCCCGGGGCACCATGGAAAATTTGGATGCTTAGGATGGCCTGCCTGGCGATAAGTGCCTACACACCTTGGGCAATTCTCCCCTCGGTCATCGGATTCTGGATAACCCTTCAGTACACAAAGAGAGGAGGTGTTCTTTGGGACACACCATCACCCAAGGAGTACAAGAAGGGTGATACCACCACTGGCGTTTACAGAATCATGACTCGAGGTCTGCTTGGCAGTTACCAAGCTGGAGCCGGAGTGATGGTAGAGGGGGTGTTCCACACACTATGGCACACCACTAAGGGAGCTGCTCTCATGAGTGGTGAGGGACGTCTGGATCCCTACTGGGGGAGCGTGAAAGAGGACCGACTTTGCTATGGGGGGCCATGGAAACTCCAACATAAATGGAATGGACATGATGAGGTCCAAATGATTGTCGTGGAGCCAGGGAAAAATGTGAAAAACGTCCAGACCAAGCCCGGAGTGTTTAAGACACCAGAAGGAGAAATTGGGGCAGTTACGCTAGACTATCCTACCGGAACGTCAGGTTCCCCCATTGTAGACAAAAATGGAGATGTGATTGGATTGTATGGGAACGGCGTCATCATGCCTAATGGTTCATACATAAGCGCCATTGTGCAAGGAGAGAGAATGGAAGAACCGGCACCAGCTGGCTTCGAACCTGAAATGTTGAGGAAGAAACAGATCACTGTCCTTGATCTGCACCCCGGAGCAGGAAAGACACGCAAGATACTTCCCCAAATCATCAAGGAGGCCATCAACAAAAGATTGAGGACGGCTGTGCTGGCACCCACCAGGGTCGTTGCTGCTGAGATGTCTGAGGCCCTGAGAGGACTTCCCATTCGGTACCAAACCTCAGCAGTGCACAGAGAGCACAGTGGAAATGAGATCGTTGATGTCATGTGCCATGCCACCCTCACACACAGGCTGATGTCTCCACACAGAGTCCCCAACTACAACCTGTTCATAATGGATGAAGCCCATTTCACGGATCCAGCGAGCATCGCAGCCAGAGGATACATAGCAACCAAGGTTGAATTGGGCGAAGCCGCCGCGATTTTCATGACGGCAACGCCACCCGGGACTTCTGACCCCTTTCCAGAGTCTAATGCTCCTATCTCGGACATGCAAACAGAGATCCCAGACAGAGCCTGGAACACTGGATATGAATGGATAACTGAGTATGTTGGAAAGACCGTTTGGTTTGTTCCAAGTGTGAAAATGGGAAATGAGATTGCCCTCTGTCTGCAACGGGCGGGGAAGAAGGTTATCCAGCTGAACAGAAAGTCCTATGAGACAGAGTACCCCAAGTGTAAGAACGATGATTGGGATTTTGTCATCACCACAGACATATCAGAAATGGGAGCCAACTTCAAGGCGAGCAGAGTGATCGACAGCCGCAAAAGCGTGAAACCCACCATCATTGAGGAAGGTGATGGAAGAGTCATCCTGGGGGAACCCTCAGCCATCACGGCTGCCAGCGCTGCTCAGCGGAGAGGACGCATAGGAAGAAACCCATCACAAGTTGGTGATGAGTATTGCTATGGAGGGCACACAAATGAGGATGATTCCAACTTTGCTCACTGGACAGAGGCTCGCATCATGCTAGACAACATCAACATGCCGAATGGTCTGGTGGCTCAACTATATCAGCCTGAGCGCGAGAAGGTGTACACCATGGACGGGGAATACAGGCTCAGAGGGGAAGAACGGAAGAACTTCCTTGAATTCCTGAGAACAGCTGATTTACCAGTCTGGCTCGCTTACAAAGTGGCAGCAGCAGGAATATCATACCATGACCGGAAATGGTGCTTTGATGGACCTCGAACCAACACGATTCTTGAAGACAACAATGAAGTTGAAGTCATCACGAAGTTGGGTGAGAGAAAGATCCTAAGACCCAGGTGGGCAGATGCTAGAGTGTACTCAGACCATCAAGCTCTAAAGTCCTTCAAAGATTTTGCATCGGGGAAACGATCACAAATCGGGCTCGTTGAGGTGCTCGGGAGAATGCCTGAACACTTCATGGTGAAAACTTGGGAGGCATTGGACACGATGTATGTGGTGGCGACCGCTGAAAAAGGAGGCCGAGCTCACAGGATGGCTCTTGAGGAGCTACCGGACGCCCTTCAGACAATAGTTTTGATTGCACTATTGAGTGTGATGTCCTTAGGTGTGTTTTTTCTACTCATGCAAAGGAAGGGCATTGGTAAGATTGGCTTGGGAGGAGTAATCTTAGGAGCTGCCACATTCTTCTGCTGGATGGCTGAAGTCCCAGGAACGAAAATAGCAGGCATGCTCCTGCTTTCCCTGCTGCTCATGATTGTTTTGATTCCGGAGCCGGAAAAGCAGCGCTCACAGACTGATAACCAGCTCGCCGTGTTCTTGATCTGTGTGCTCACACTGGTCGGCGCCGTGGCTGCCAATGAAATGGGCTGGCTGGACAAGACCAAGAATGACATTGGCAGCCTGTTGGGGCACAGGCCAGAAGCTAGAGAGACGACCCTGGGAGTTGAGAGCTTCTTACTTGATCTGCGGCCGGCCACGGCATGGTCGCTCTATGCCGTAACGACAGCCGTTCTCACCCCTTTGCTGAAGCATCTAATCACGTCAGACTACATCAACACTTCGTTGACCTCAATAAACGTCCAAGCCAGCGCGTTGTTCACTTTGGCCAGAGGCTTCCCTTTTGTGGACGTTGGTGTGTCAGCTCTCTTGCTGGCGGTCGGGTGCTGGGGTCAGGTGACTCTGACTGTGACTGTGACTGCAGCTGCTCTGCTCTTTTGCCACTATGCTTACATGGTGCCAGGCTGGCAAGCGGAAGCCATGCGATCTGCCCAGCGGCGGACAGCTGCTGGCATCATGAAAAATGTAGTGGTGGATGGGATCGTGGCCACTGATGTACCTGAACTTGAACGAACAACTCCAGTCATGCAGAAAAAAGTTGGACAGATCATATTGATCTTGGTATCAATGGCCGCGGTGGTCGTCAATCCATCAGTGAGAACCGTCAGAGAGGCCGGAATTCTGACTACAGCAGCAGCAGTCACCCTATGGGAGAATGGTGCTAGTTCAGTGTGGAATGCAACGACAGCTATTGGCCTTTGTCACATCATGCGAGGAGGATGGCTCTCGTGTCTCTCCATCATGTGGACTCTCATCAAAAACATGGAGAAACCAGGCCTCAAGAGGGGTGGAGCCAAAGGACGCACGCTAGGGGAAGTTTGGAAGGAGAGACTCAACCACATGACGAAGGAAGAATTTACCAGATACAGAAAAGAAGCCATCACTGAAGTTGACCGCTCCGCAGCAAAACATGCTAGGAGAGAGGGAAACATCACTGGAGGCCACCCAGTCTCACGGGGAACCGCGAAATTACGGTGGTTAGTGGAAAGGCGTTTCCTCGAGCCAGTGGGAAAGGTTGTGGATCTCGGGTGTGGTAGAGGCGGCTGGTGCTATTACATGGCTACCCAGAAGAGGGTACAGGAAGTGAAAGGGTACACGAAAGGAGGACCTGGCCATGAAGAACCACAACTGGTGCAGAGCTATGGTTGGAATATTGTTACCATGAAGAGTGGAGTCGACGTCTTCTACAGACCATCAGAAGCGAGCGACACACTGCTCTGTGACATTGGAGAGTCATCGTCAAGTGCCGAGGTAGAAGAACACCGCACCGTCCGTGTCCTGGAGATGGTGGAAGATTGGTTGCACAGAGGACCGAAGGAATTCTGCATCAAAGTGCTATGCCCTTACATGCCCAAAGTGATTGAGAAGATGGAAACACTCCAAAGGCGATATGGAGGTGGCCTTATAAGAAACCCCCTTTCACGCAACTCTACCCATGAGATGTACTGGGTGAGCCACGCTTCAGGCAATATCGTCCACTCCGTCAACATGACAAGCCAGGTGCTTCTGGGGAGGATGGAAAAGAAAACATGGAAGGGACCCCAGTTTGAGGAAGATGTCAACTTGGGAAGTGGAACGCGGGCAGTAGGGAAGCCTCTCCTCAATTCTGATACTAGCAAGATCAAGAACCGAATTGAGAGGCTGAAGAAAGAATACAGCTCCACATGGCACCAGGATGCGAACCACCCCTACAGGACCTGGAACTACCACGGAAGCTATGAAGTGAAACCAACCGGCTCAGCCAGCTCCCTTGTGAATGGGGTAGTCAGATTACTCTCAAAACCATGGGACACTATCACCAATGTGACCACGATGGCCATGACAGACACCACTCCTTTCGGTCAACAACGAGTGTTCAAGGAAAAGGTGGACACAAAGGCTCCAGAGCCTCCAGAAGGAGTCAAATACGTCCTCAATGAGACCACGAACTGGCTGTGGGCTTTTTTAGCCCGCGATAAGAAACCCAGGATGTGTTCCCGGGAGGAATTTATTGGAAAAGTCAACAGTAATGCCGCCCTAGGAGCGATGTTTGAAGAACAGAACCAATGGAAGAACGCCCGGGAAGCTGTAGAGGATCCAAAGTTTTGGGAGATGGTGGATGAGGAGCGTGAAGCGCATCTCCGTGGAGAATGCAACACCTGCATCTACAACATGATGGGAAAGAGAGAGAAGAAGCCTGGAGAGTTCGGCAAAGCTAAAGGCAGCAGAGCCATCTGGTTCATGTGGCTGGGGGCCCGCTTCCTGGAGTTTGAAGCTCTCGGATTCCTCAATGAAGACCACTGGCTGGGTAGGAAGAACTCAGGAGGAGGAGTTGAAGGCTTAGGACTGCAGAAGCTCGGGTACATCTTGAAGGAAGTTGGAACAAAGCCTGGAGGAAAGGTTTACGCTGATGATACCGCAGGCTGGGACACACGCATCACCAAAGCTGACCTCGAGAATGAAGCGAAGGTTCTTGAACTGCTGGATGGAGAACATCGACGTTTAGCGCGGTCCATCATCGAGCTCACATACCGACACAAAGTCGTGAAAGTGATGAGGCCAGCGGCCGACGGGAAAACTGTGATGGACGTCATCTCTAGAGAGGATCAGAGAGGAAGCGGTCAGGTAGTGACTTACGCCCTGAACACCTTCACCAATCTAGCAGTTCAGCTGGTCAGAATGATGGAGGGGGAGGGGGTCATTGGACCCGATGATGTTGAAAAACTGGGAAAAGGAAAAGGCCCTAAGGTCAGAACCTGGCTGTTTGAGAATGGCGAGGAGCGTCTCAGTCGCATGGCCGTCAGCGGTGATGACTGCGTGGTGAAACCTTTGGACGACCGCTTCGCCACATCACTACACTTCCTAAATGCTATGTCAAAGGTCCGCAAAGACATCCAGGAATGGAAACCCTCGACGGGGTGGTATGACTGGCAGCAGGTTCCATTCTGTTCAAACCATTTCACGGAACTGATCATGAAGGACGGCAGGACGCTGGTGGTCCCGTGTCGTGGACAAGACGAGTTGATTGGACGTGCCAGGATCTCTCCAGGGGCTGGATGGAATGTGCGCGACACCGCCTGCCTGGCGAAGTCATACGCGCAGATGTGGCTGCTGCTTTATTTCCACCGTAGAGACCTGAGATTGATGGCCAATGCCATCTGTTCCGCTGTGCCTGCCAACTGGGTTCCCACAGGGCGTACCACTTGGTCGATCCACGCAAAAGGAGAATGGATGACGACGGAAGACATGCTCGCAGTCTGGAACAGAGTGTGGATTGAGGAGAATGAGTGGATGGAAGACAAAACACCAGTTGAGAGGTGGAGTGATGTTCCATACTCTGGAAAGAGAGAGGACATTTGGTGTGGCAGTTTGATCGGCACACGAACCCGCGCCACTTGGGCTGAAAATATCCATGTGGCAATCAATCAGGTCCGTTCAGTGATTGGAGAAGAGAAGTATGTGGATTACATGAGCTCCTTGAGGAGGTATGAAGACACCATTGTAGTGGAGGACACTGTTTTGTAAAAGATAGTATTATAGTTAGTTTAGTGTAAATAGGATTTATTGAGAATGGAAGTCAGGCCAGATTAATGCTGCCACCGGAAGTTGAGTAGACGGTGCTGCCTGCGGCTCAACCCCAGGAGGACTGGGTGACCAAAGCTGCGAGGTGATCCACGTAAGCCCTCAGAACCGTCTCGGAAGGAGGACCCCACGTGCTTTAGCCTCAAAGCCCAGTGTCAGACCACACTTTAATGTGCCACTCTGCGGAGAGTGCAGTCTGCGATAGTGCCCCAGGTGGACTGGGTTAACAAAGGCAAAACATCGCCCCACGCGGCCATAACCCTGGCTATGGTGTTAACCAGGGAGAAGGGACTAGAGGTTAGAGGAGACCCCGCGTAAAAAAGTGCACGGCCCAACTTGGCTGAAGCTGTAAGCCAAGGGAAGGACTAGAGGTTAGAGGAGACCCCGTGCCAAAAACACCAAAAGAAACAGCATATTGACACCTGGGATAGACTAGGGGATCTTCTGCTCTGCACAACCAGCCACACGGCACAGTGCGCCGACATAGGTGGCTGGTGGTGCTAGAACACAGGATCT</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Virion</CellLocal>
      <Ontology_ID>GO:0019012</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Virion membrane</CellLocal>
      <Ontology_ID>GO:0055036</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Viral envelope protein</CellLocal>
      <Ontology_ID>KW-0261</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host nucleus</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell membrane</CellLocal>
      <Ontology_ID>GO:0033644</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Viral capsid</CellLocal>
      <Ontology_ID>GO:0019028</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell nucleus</CellLocal>
      <Ontology_ID>GO:0042025</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Viral envelope</CellLocal>
      <Ontology_ID>GO:0019031</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell endoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>GO:0044167</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host endoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Host cell endoplasmic reticulum</CellLocal>
      <Ontology_ID>GO:0044165</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_ID>912267</Gene_ID>
    <Genbank_ACCN>NC_001563</Genbank_ACCN>
    <Protein_ACCN>NP_041724</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/912267</Gene_URL>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P05106</Uniprot_ID>
      <Gene_Name>ITGB3</Gene_Name>
      <EBI_ID>EBI-702847</EBI_ID>
      <PPI_EBI_URL>EBI-981051,EBI-702847</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q17NZ6</Uniprot_ID>
      <Gene_Name>CTLMA15</Gene_Name>
      <EBI_ID>EBI-2912457</EBI_ID>
      <PPI_EBI_URL>EBI-981051,EBI-2912457</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
  </PPI_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Hepatitis C Virus polymerase NS5B (BK) with fragment-based compounds</PDB_Title>
      <PDB_ID>4IH7</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4IH7</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740255</ASD_Ligand>
      <PubMed_Title>De novo fragment design: a medicinal chemistry approach to fragment-based lead generation.</PubMed_Title>
      <Author>Talamas, F.X., et al.</Author>
      <Journal>J.Med.Chem.(2013)56:3115-3119</Journal>
      <PubMed_ID>23509929</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitor</PDB_Title>
      <PDB_ID>3CVK</PDB_ID>
      <Resolution>2.31</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CVK</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740267</ASD_Ligand>
      <PubMed_Title>Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.</PubMed_Title>
      <Author>Ruebsam, F., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:5002-5005</Journal>
      <PubMed_ID>18722768</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HCV NS5B GT1B N316 with GSK5852A</PDB_Title>
      <PDB_ID>4KAI</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4KAI</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740240</ASD_Ligand>
      <PubMed_Title>Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.</PubMed_Title>
      <Author>Maynard, A., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1902-1913</Journal>
      <PubMed_ID>23672667</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of HCV NS5B RNA polymerase in complex with PF868554</PDB_Title>
      <PDB_ID>3FRZ</PDB_ID>
      <Resolution>1.86</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3FRZ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD09990001</ASD_Ligand>
      <PubMed_Title>Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.</PubMed_Title>
      <Author>Li, H., et al.</Author>
      <Journal>J.Med.Chem.(2009)52:1255-1258</Journal>
      <PubMed_ID>19209845</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HCV NS5B GT1B N316Y with CMPD 32</PDB_Title>
      <PDB_ID>4KB7</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4KB7</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740274</ASD_Ligand>
      <PubMed_Title>Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.</PubMed_Title>
      <Author>Maynard, A., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1902-1913</Journal>
      <PubMed_ID>23672667</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HCV NS5B polymerase inhibitors: Tri-substituted acylhydrazines as tertiary amide bioisosteres</PDB_Title>
      <PDB_ID>4EO6</PDB_ID>
      <Resolution>1.79</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4EO6</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740242</ASD_Ligand>
      <PubMed_Title>Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors.</PubMed_Title>
      <Author>Canales, E., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2012)22:4288-4292</Journal>
      <PubMed_ID>22664130</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor</PDB_Title>
      <PDB_ID>3CWJ</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CWJ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740265</ASD_Ligand>
      <PubMed_Title>4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase</PubMed_Title>
      <Author>Ellis, D.A., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:4628-4632</Journal>
      <PubMed_ID>18662878</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase in complex with a novel bicyclic dihydro-pyridinone inhibitor</PDB_Title>
      <PDB_ID>3H2L</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3H2L</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740262</ASD_Ligand>
      <PubMed_Title>Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase.</PubMed_Title>
      <Author>Ruebsam, F., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2009)19:6404-6412</Journal>
      <PubMed_ID>19818610</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HCV NS5B GT1B N316Y with CMPD 4</PDB_Title>
      <PDB_ID>4KBI</PDB_ID>
      <Resolution>2.06</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4KBI</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740269</ASD_Ligand>
      <PubMed_Title>Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.</PubMed_Title>
      <Author>Maynard, A., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1902-1913</Journal>
      <PubMed_ID>23672667</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitor</PDB_Title>
      <PDB_ID>3CO9</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CO9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740261</ASD_Ligand>
      <PubMed_Title>Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.</PubMed_Title>
      <Author>Ruebsam, F., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:3616-3621</Journal>
      <PubMed_ID>18487044</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitor</PDB_Title>
      <PDB_ID>3BSA</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3BSA</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740270</ASD_Ligand>
      <PubMed_Title>Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.</PubMed_Title>
      <Author>Zhou, Y., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:1413-1418</Journal>
      <PubMed_ID>18242088</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 2 (3-(3-tert-butyl-4-methoxyphenyl)pyridin-2(1H)-one)</PDB_Title>
      <PDB_ID>4MK7</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4MK7</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740256</ASD_Ligand>
      <PubMed_Title>Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.</PubMed_Title>
      <Author>Schoenfeld, R.C., et al.</Author>
      <Journal>J.Med.Chem.(2013)56:8163-8182</Journal>
      <PubMed_ID>24069953</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>IDENTIFICATION OF NOVEL ALLOSTERIC INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE THUMB DOMAIN (SITE II) BY STRUCTURE-BASED DESIGN</PDB_Title>
      <PDB_ID>2WRM</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WRM</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01410467</ASD_Ligand>
      <PubMed_Title>Identification of Novel Allosteric Inhibitors of Hepatitis C Virus Ns5B Polymerase Thumb Domain (Site II) by Structure-Based Design</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitor</PDB_Title>
      <PDB_ID>1NHV</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NHV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01410468</ASD_Ligand>
      <PubMed_Title>Non-Nucleoside Analogue Inhibitors Bind to an Allosteric Site on HCV NS5B Polymerase: Crystal Structures and Mechanism of Inhibition</PubMed_Title>
      <Author>Wang, M., et al.</Author>
      <Journal>J.Biol.Chem.(2003)278:9489-9495</Journal>
      <PubMed_ID>12509436</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C virus polymerase NS5B (BK) with amide bioisostere thumb site inhibitor</PDB_Title>
      <PDB_ID>3MF5</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3MF5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740239</ASD_Ligand>
      <PubMed_Title>Cyclic amide bioisosterism: Strategic application to the design and synthesis of HCV NS5B polymerase inhibitors.</PubMed_Title>
      <Author>Yang, H., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2010)20:4614-4619</Journal>
      <PubMed_ID>20584604</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of NS5B BK strain (delta 24) in complex with a 3-(1,1-Dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinone</PDB_Title>
      <PDB_ID>2FVC</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FVC</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740228</ASD_Ligand>
      <PubMed_Title>3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.</PubMed_Title>
      <Author>Tedesco, R., et al.</Author>
      <Journal>J.Med.Chem.(2006)49:971-983</Journal>
      <PubMed_ID>16451063</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the West Nile virus NS2B-NS3 protease, His51Ala mutant</PDB_Title>
      <PDB_ID>2GGV</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GGV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold.</PubMed_Title>
      <Author>Aleshin, A.E., et al.</Author>
      <Journal>Protein Sci.(2007)16:795-806</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17400917?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>West Nile vi rus NS2B-NS3protease in complexed with inhibitor Naph-KKR-H</PDB_Title>
      <PDB_ID>3E90</PDB_ID>
      <Resolution>2.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3E90</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation</PubMed_Title>
      <Author>Robin, G., et al.</Author>
      <Journal>J.Mol.Biol.(2009)385:1568-1577</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19059417?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 14 (N-(4-{(E)-2-[3-tert-butyl-2-methoxy-5-(3-oxo-2,3-dihydropyridazin-4-yl)phenyl]ethenyl}phenyl)methanesulfonamide)</PDB_Title>
      <PDB_ID>4MKB</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4MKB</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740263</ASD_Ligand>
      <PubMed_Title>Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.</PubMed_Title>
      <Author>Schoenfeld, R.C., et al.</Author>
      <Journal>J.Med.Chem.(2013)56:8163-8182</Journal>
      <PubMed_ID>24069953</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure Analysis of the West Nile virus envelope (E) protein domain III</PDB_Title>
      <PDB_ID>2P5P</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2P5P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure Analysis of the West Nile virus envelope (E) protein domain III</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>HCV NS5B GT1B N316Y with GSK5852</PDB_Title>
      <PDB_ID>4KE5</PDB_ID>
      <Resolution>2.11</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4KE5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740240</ASD_Ligand>
      <PubMed_Title>Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.</PubMed_Title>
      <Author>Maynard, A., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1902-1913</Journal>
      <PubMed_ID>23672667</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitor</PDB_Title>
      <PDB_ID>3E51</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3E51</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740253</ASD_Ligand>
      <PubMed_Title>Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents.</PubMed_Title>
      <Author>Dragovich, P.S., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:5635-5639</Journal>
      <PubMed_ID>18796353</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the West Nile virus NS2B-NS3 protease complexed with bovine pancreatic trypsin inhibitor</PDB_Title>
      <PDB_ID>2IJO</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2IJO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold.</PubMed_Title>
      <Author>Aleshin, A.E., et al.</Author>
      <Journal>Protein Sci.(2007)16:795-806</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17400917?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB655264</PDB_Title>
      <PDB_ID>2JC0</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JC0</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740225</ASD_Ligand>
      <PubMed_Title>Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate.</PubMed_Title>
      <Author>Slater, M.J., et al.</Author>
      <Journal>J.Med.Chem.(2007)50:897</Journal>
      <PubMed_ID>17269759</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with Compound 48 (N-({(3S)-1-[6-tert-butyl-5-methoxy-8-(2-oxo-1,2-dihydropyridin-3-yl)quinolin-3-yl]pyrrolidin-3-yl}methyl)methanesulfonamide)</PDB_Title>
      <PDB_ID>4MIB</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4MIB</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740264</ASD_Ligand>
      <PubMed_Title>Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymerase.</PubMed_Title>
      <Author>Talamas, F.X., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1914-1931</Journal>
      <PubMed_ID>24195700</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitor</PDB_Title>
      <PDB_ID>3BR9</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3BR9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740260</ASD_Ligand>
      <PubMed_Title>Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.</PubMed_Title>
      <Author>Zhou, Y., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:1413-1418</Journal>
      <PubMed_ID>18242088</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B RNA polymerase complexed with a tetracyclic inhibitor</PDB_Title>
      <PDB_ID>2DXS</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DXS</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740246</ASD_Ligand>
      <PubMed_Title>Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</PubMed_Title>
      <Author>Ikegashira, K., et al.</Author>
      <Journal>J.Med.Chem.(2006)49:6950-6953</Journal>
      <PubMed_ID>17125247</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 13 (N-{2-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydropyridin-3-yl)phenyl]-1,3-benzoxazol-5-yl}methanesulfonamide)</PDB_Title>
      <PDB_ID>4MKA</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4MKA</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740250</ASD_Ligand>
      <PubMed_Title>Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.</PubMed_Title>
      <Author>Schoenfeld, R.C., et al.</Author>
      <Journal>J.Med.Chem.(2013)56:8163-8182</Journal>
      <PubMed_ID>24069953</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 4 (N-(4-{2-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydropyridin-3-yl)phenyl]ethyl}phenyl)methanesulfonamide)</PDB_Title>
      <PDB_ID>4MK8</PDB_ID>
      <Resolution>2.09</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4MK8</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740257</ASD_Ligand>
      <PubMed_Title>Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.</PubMed_Title>
      <Author>Schoenfeld, R.C., et al.</Author>
      <Journal>J.Med.Chem.(2013)56:8163-8182</Journal>
      <PubMed_ID>24069953</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB698223</PDB_Title>
      <PDB_ID>2JC1</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JC1</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740227</ASD_Ligand>
      <PubMed_Title>Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate.</PubMed_Title>
      <Author>Slater, M.J., et al.</Author>
      <Journal>J.Med.Chem.(2007)50:897</Journal>
      <PubMed_ID>17269759</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B RNA polymerase with a novel piperazine inhibitor</PDB_Title>
      <PDB_ID>3VQS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQS</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740281</ASD_Ligand>
      <PubMed_Title>Preclinical Characterization of JTK-853, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase.</PubMed_Title>
      <Author>Ando, I., et al.</Author>
      <Journal>Antimicrob.Agents Chemother.(2012)56:4250-4256</Journal>
      <PubMed_ID>22615294</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>West Nile Virus NS2B-NS3 protease in complex with 3,4- dichlorophenylacetyl-Lys-Lys-GCMA</PDB_Title>
      <PDB_ID>2YOL</PDB_ID>
      <Resolution>3.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2YOL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Development and Characterization of New Peptidomimetic Inhibitors of the West Nile Virus Ns2B-Ns3 Protease.</PubMed_Title>
      <Author>Hammamy, M.Z., et al.</Author>
      <Journal>Chemmedchem(2013)8:231</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23307694?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 12 (N-{2-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydropyridin-3-yl)phenyl]-1,3-benzoxazol-5-yl}methanesulfonamide)</PDB_Title>
      <PDB_ID>4MK9</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4MK9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740272</ASD_Ligand>
      <PubMed_Title>Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.</PubMed_Title>
      <Author>Schoenfeld, R.C., et al.</Author>
      <Journal>J.Med.Chem.(2013)56:8163-8182</Journal>
      <PubMed_ID>24069953</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of hcv ns5b polymerase with a novel benzisothiazole inhibitor</PDB_Title>
      <PDB_ID>3D28</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3D28</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740268</ASD_Ligand>
      <PubMed_Title>Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.</PubMed_Title>
      <Author>Kim, S.H., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:4181-4185</Journal>
      <PubMed_ID>18554907</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B RNA polymerase complexed with a novel non-competitive inhibitor.</PDB_Title>
      <PDB_ID>1OS5</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1OS5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740210</ASD_Ligand>
      <PubMed_Title>Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme.</PubMed_Title>
      <Author>Love, R.A., et al.</Author>
      <Journal>J.Virol.(2003)77:7575-7581</Journal>
      <PubMed_ID>12805457</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5b 1b with (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyrimidine derivative</PDB_Title>
      <PDB_ID>3H98</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3H98</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740258</ASD_Ligand>
      <PubMed_Title>HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives.</PubMed_Title>
      <Author>Wang, G., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2009)19:4480-4483</Journal>
      <PubMed_ID>19500983</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HCV NS5B polymerase inhibitors: Tri-substituted acylhydrazines as tertiary amide bioisosteres</PDB_Title>
      <PDB_ID>4EO8</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4EO8</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740238</ASD_Ligand>
      <PubMed_Title>Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors.</PubMed_Title>
      <Author>Canales, E., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2012)22:4288-4292</Journal>
      <PubMed_ID>22664130</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydropyridinone inhibitor</PDB_Title>
      <PDB_ID>3GYN</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GYN</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740280</ASD_Ligand>
      <PubMed_Title>5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.</PubMed_Title>
      <Author>Ellis, D.A., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2009)19:6047-6052</Journal>
      <PubMed_ID>19796938</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitor</PDB_Title>
      <PDB_ID>3D5M</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3D5M</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740275</ASD_Ligand>
      <PubMed_Title>Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.</PubMed_Title>
      <Author>Kim, S.H., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:4181-4185</Journal>
      <PubMed_ID>18554907</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with RG7109 (N-{4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-2,5-dihydropyridin-3-yl)quinolin-3-yl]phenyl}methanesulfonamide)</PDB_Title>
      <PDB_ID>4MIA</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4MIA</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740247</ASD_Ligand>
      <PubMed_Title>Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymerase.</PubMed_Title>
      <Author>Talamas, F.X., et al.</Author>
      <Journal>J.Med.Chem.(2014)57:1914-1931</Journal>
      <PubMed_ID>24195700</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C Virus polymerase NS5B (BK) with fragment-based compounds</PDB_Title>
      <PDB_ID>4IH5</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4IH5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740254</ASD_Ligand>
      <PubMed_Title>De novo fragment design: a medicinal chemistry approach to fragment-based lead generation.</PubMed_Title>
      <Author>Talamas, F.X., et al.</Author>
      <Journal>J.Med.Chem.(2013)56:3115-3119</Journal>
      <PubMed_ID>23509929</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>West Nile Virus NS2B/NS3protease in complex with Bz-Nle-Lys-Arg-Arg-H</PDB_Title>
      <PDB_ID>2FP7</PDB_ID>
      <Resolution>1.68</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FP7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.</PubMed_Title>
      <Author>Erbel, P., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2006)13:372-373</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16532006?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Hepatitis C Virus polymerase NS5B (BK) with fragment-based compounds</PDB_Title>
      <PDB_ID>4IH6</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4IH6</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740249</ASD_Ligand>
      <PubMed_Title>De novo fragment design: a medicinal chemistry approach to fragment-based lead generation.</PubMed_Title>
      <Author>Talamas, F.X., et al.</Author>
      <Journal>J.Med.Chem.(2013)56:3115-3119</Journal>
      <PubMed_ID>23509929</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitor</PDB_Title>
      <PDB_ID>3BSC</PDB_ID>
      <Resolution>2.65</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3BSC</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740259</ASD_Ligand>
      <PubMed_Title>Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.</PubMed_Title>
      <Author>Zhou, Y., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:1413-1418</Journal>
      <PubMed_ID>18242088</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase with a novel Pyridazinone inhibitor</PDB_Title>
      <PDB_ID>3CDE</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CDE</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740248</ASD_Ligand>
      <PubMed_Title>Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments.</PubMed_Title>
      <Author>Li, L.S., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2008)18:3446-3455</Journal>
      <PubMed_ID>18457949</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the West Nile Virus envelope glycoprotein in complex with the E53 antibody Fab</PDB_Title>
      <PDB_ID>3I50</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3I50</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.</PubMed_Title>
      <Author>Cherrier, M.V., et al.</Author>
      <Journal>Embo J.(2009)28:3269-3276</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19713934?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydro-pyridinone inhibitor</PDB_Title>
      <PDB_ID>3IGV</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3IGV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03740271</ASD_Ligand>
      <PubMed_Title>5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.</PubMed_Title>
      <Author>Ellis, D.A., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2009)19:6047-6052</Journal>
      <PubMed_ID>19796938</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.ia.b.d.h.html</SCOP_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Saalau-Bethell SM, et al. Nat Chem Biol. 2012 Nov;8(11):920-5. doi: 10.1038/nchembio.1081.</Site_Reference>
      <PubMed_ID>23023261</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD01410015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01410051</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01410351</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01410467</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01410468</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01411053</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01418022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740035</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740036</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740037</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740038</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740039</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740040</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740041</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740042</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740047</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740048</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740049</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740050</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740051</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740052</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740053</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740054</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740055</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740056</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740057</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740058</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740059</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740060</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740061</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740062</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740063</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740064</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740065</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740066</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740067</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740068</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740069</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740070</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740071</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740072</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740073</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740074</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740075</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740076</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740077</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740078</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740079</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740080</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740081</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740082</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740083</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740084</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740085</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740086</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740087</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740088</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740089</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740090</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740091</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740092</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740093</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740094</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740095</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740096</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740097</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740098</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740099</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740100</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740101</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740102</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740103</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740104</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740105</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740106</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740107</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740108</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740109</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740110</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740111</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740112</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740113</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740114</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740115</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740116</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740117</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740118</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740119</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740120</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740121</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740122</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740123</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740124</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740125</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740126</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740127</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740128</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740129</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740130</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740131</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740132</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740133</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740134</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740135</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740136</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740137</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740138</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740139</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740140</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740141</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740142</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740143</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740144</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740145</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740146</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740147</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740148</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740149</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740150</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740151</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740152</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740153</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740154</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740155</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740156</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740157</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740158</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740159</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740160</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740161</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740162</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740163</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740164</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740165</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740166</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740167</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740168</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740169</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740170</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740171</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740172</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740173</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740174</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740175</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740176</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740177</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740178</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740179</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740180</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740181</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740182</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740184</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740185</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740186</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740187</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740188</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740189</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740190</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740191</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740192</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740193</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740194</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740195</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740196</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740197</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740198</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740199</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740200</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740201</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740202</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740203</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740205</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740207</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740210</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740218</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740219</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740220</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740225</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740227</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740228</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740234</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740235</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740236</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740237</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740238</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740239</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740240</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740241</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740242</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740243</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740244</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740246</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740247</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740248</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740249</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740250</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740253</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740254</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740255</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740256</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740257</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740258</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740259</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740260</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740261</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740262</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740263</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740264</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740265</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740266</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740267</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740268</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740269</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740270</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740271</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740272</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740273</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740274</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740275</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740276</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740277</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740278</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740279</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740280</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03740281</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09990001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2013-07-23</Create_Date>
</Organism_Record>